Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 270

1.

Regulatory T Cell-Mediated Suppression of Inflammation Induced by DR3 Signaling Is Dependent on Galectin-9.

Madireddi S, Eun SY, Mehta AK, Birta A, Zajonc DM, Niki T, Hirashima M, Podack ER, Schreiber TH, Croft M.

J Immunol. 2017 Oct 15;199(8):2721-2728. doi: 10.4049/jimmunol.1700575. Epub 2017 Sep 6.

PMID:
28877989
2.

MPEG1/perforin-2 mutations in human pulmonary nontuberculous mycobacterial infections.

McCormack RM, Szymanski EP, Hsu AP, Perez E, Olivier KN, Fisher E, Goodhew EB, Podack ER, Holland SM.

JCI Insight. 2017 Apr 20;2(8). pii: 89635. doi: 10.1172/jci.insight.89635. [Epub ahead of print]

3.

Cancer-testis antigen expression is shared between epithelial ovarian cancer tumors.

Garcia-Soto AE, Schreiber T, Strbo N, Ganjei-Azar P, Miao F, Koru-Sengul T, Simpkins F, Nieves-Neira W, Lucci J 3rd, Podack ER.

Gynecol Oncol. 2017 Jun;145(3):413-419. doi: 10.1016/j.ygyno.2017.03.512. Epub 2017 Apr 6.

PMID:
28392126
4.

Marked in Vivo Donor Regulatory T Cell Expansion via Interleukin-2 and TL1A-Ig Stimulation Ameliorates Graft-versus-Host Disease but Preserves Graft-versus-Leukemia in Recipients after Hematopoietic Stem Cell Transplantation.

Wolf D, Barreras H, Bader CS, Copsel S, Lightbourn CO, Pfeiffer BJ, Altman NH, Podack ER, Komanduri KV, Levy RB.

Biol Blood Marrow Transplant. 2017 May;23(5):757-766. doi: 10.1016/j.bbmt.2017.02.013. Epub 2017 Feb 20.

5.

Killing of Microbes and Cancer by the Immune System with Three Mammalian Pore-Forming Killer Proteins.

Podack ER, Munson GP.

Front Immunol. 2016 Nov 3;7:464. eCollection 2016. Review.

6.

Corrigendum: Distinct Transcriptomic Features Are Associated with Transitional and Mature B-Cell Populations in the Mouse Spleen.

Kleiman E, Salyakina D, De Heusch M, Hoek KL, Llanes JM, Castro I, Wright JA, Clark ES, Dykxhoorn DM, Capobianco E, Takeda A, McCormack RM, Podack ER, Renauld JC, Khan WN.

Front Immunol. 2016 Jul 4;7:267. doi: 10.3389/fimmu.2016.00267. eCollection 2016.

7.

Bacterial Vaginosis Is Associated with Loss of Gamma Delta T Cells in the Female Reproductive Tract in Women in the Miami Women Interagency HIV Study (WIHS): A Cross Sectional Study.

Alcaide ML, Strbo N, Romero L, Jones DL, Rodriguez VJ, Arheart K, Martinez O, Bolivar H, Podack ER, Fischl MA.

PLoS One. 2016 Apr 14;11(4):e0153045. doi: 10.1371/journal.pone.0153045. eCollection 2016.

8.

Perforin-2 Protects Host Cells and Mice by Restricting the Vacuole to Cytosol Transitioning of a Bacterial Pathogen.

McCormack R, Bahnan W, Shrestha N, Boucher J, Barreto M, Barrera CM, Dauer EA, Freitag NE, Khan WN, Podack ER, Schesser K.

Infect Immun. 2016 Mar 24;84(4):1083-1091. doi: 10.1128/IAI.01434-15. Print 2016 Apr.

9.

Loss of Intra-Epithelial Endocervical Gamma Delta (GD) 1 T Cells in HIV-Infected Women.

Strbo N, Alcaide ML, Romero L, Bolivar H, Jones D, Podack ER, Fischl MA.

Am J Reprod Immunol. 2016 Feb;75(2):134-45. doi: 10.1111/aji.12458. Epub 2015 Dec 15.

10.

Enteric pathogens deploy cell cycle inhibiting factors to block the bactericidal activity of Perforin-2.

McCormack RM, Lyapichev K, Olsson ML, Podack ER, Munson GP.

Elife. 2015 Sep 29;4. pii: e06505. doi: 10.7554/eLife.06505.

11.

Perforin-2 is essential for intracellular defense of parenchymal cells and phagocytes against pathogenic bacteria.

McCormack RM, de Armas LR, Shiratsuchi M, Fiorentino DG, Olsson ML, Lichtenheld MG, Morales A, Lyapichev K, Gonzalez LE, Strbo N, Sukumar N, Stojadinovic O, Plano GV, Munson GP, Tomic-Canic M, Kirsner RS, Russell DG, Podack ER.

Elife. 2015 Sep 24;4. pii: e06508. doi: 10.7554/eLife.06508.

12.

Perforin-2/Mpeg1 and other pore-forming proteins throughout evolution.

McCormack R, Podack ER.

J Leukoc Biol. 2015 Nov;98(5):761-8. doi: 10.1189/jlb.4MR1114-523RR. Epub 2015 Aug 25. Review.

13.

Statistical Considerations in Clinical Trial Design of Immunotherapeutic Cancer Agents.

Dranitsaris G, Cohen RB, Acton G, Keltner L, Price M, Amir E, Podack ER, Schreiber TH.

J Immunother. 2015 Sep;38(7):259-66. doi: 10.1097/CJI.0000000000000089.

PMID:
26261889
14.

Pulmonary Nontuberculous Mycobacterial Infection. A Multisystem, Multigenic Disease.

Szymanski EP, Leung JM, Fowler CJ, Haney C, Hsu AP, Chen F, Duggal P, Oler AJ, McCormack R, Podack E, Drummond RA, Lionakis MS, Browne SK, Prevots DR, Knowles M, Cutting G, Liu X, Devine SE, Fraser CM, Tettelin H, Olivier KN, Holland SM.

Am J Respir Crit Care Med. 2015 Sep 1;192(5):618-28. doi: 10.1164/rccm.201502-0387OC.

15.

Immunological mechanisms of the antitumor effects of supplemental oxygenation.

Hatfield SM, Kjaergaard J, Lukashev D, Schreiber TH, Belikoff B, Abbott R, Sethumadhavan S, Philbrook P, Ko K, Cannici R, Thayer M, Rodig S, Kutok JL, Jackson EK, Karger B, Podack ER, Ohta A, Sitkovsky MV.

Sci Transl Med. 2015 Mar 4;7(277):277ra30. doi: 10.1126/scitranslmed.aaa1260.

16.

CD30 ligand is a new therapeutic target for central nervous system autoimmunity.

Shinoda K, Sun X, Oyamada A, Yamada H, Muta H, Podack ER, Kira J, Yoshikai Y.

J Autoimmun. 2015 Feb;57:14-23. doi: 10.1016/j.jaut.2014.11.005. Epub 2014 Dec 19.

PMID:
25533628
17.

Multiple low-dose challenges in a rhesus macaque AIDS vaccine trial result in an evolving host response that affects protective outcome.

Selinger C, Strbo N, Gonzalez L, Aicher L, Weiss JM, Law GL, Palermo RE, Vaccari M, Franchini G, Podack ER, Katze MG.

Clin Vaccine Immunol. 2014 Dec;21(12):1650-60. doi: 10.1128/CVI.00455-14. Epub 2014 Oct 1.

18.

Systemic oxygenation weakens the hypoxia and hypoxia inducible factor 1α-dependent and extracellular adenosine-mediated tumor protection.

Hatfield SM, Kjaergaard J, Lukashev D, Belikoff B, Schreiber TH, Sethumadhavan S, Abbott R, Philbrook P, Thayer M, Shujia D, Rodig S, Kutok JL, Ren J, Ohta A, Podack ER, Karger B, Jackson EK, Sitkovsky M.

J Mol Med (Berl). 2014 Dec;92(12):1283-92. doi: 10.1007/s00109-014-1189-3. Epub 2014 Aug 15.

19.

Heat shock protein vaccination and directed IL-2 therapy amplify tumor immunity rapidly following bone marrow transplantation in mice.

Newman RG, Dee MJ, Malek TR, Podack ER, Levy RB.

Blood. 2014 May 8;123(19):3045-55. doi: 10.1182/blood-2013-08-520775. Epub 2014 Mar 31.

20.

B cell regulation of anti-tumor immune response.

Zhang Y, Morgan R, Podack ER, Rosenblatt J.

Immunol Res. 2013 Dec;57(1-3):115-24. doi: 10.1007/s12026-013-8472-1. Review.

PMID:
24293009
21.

Killing machines: three pore-forming proteins of the immune system.

McCormack R, de Armas L, Shiratsuchi M, Podack ER.

Immunol Res. 2013 Dec;57(1-3):268-78. doi: 10.1007/s12026-013-8469-9. Review.

22.

The allure and peril of hematopoietic stem cell transplantation: overcoming immune challenges to improve success.

Newman RG, Ross DB, Barreras H, Herretes S, Podack ER, Komanduri KV, Perez VL, Levy RB.

Immunol Res. 2013 Dec;57(1-3):125-39. doi: 10.1007/s12026-013-8450-7. Review.

23.

Secreted heat shock protein gp96-Ig: next-generation vaccines for cancer and infectious diseases.

Strbo N, Garcia-Soto A, Schreiber TH, Podack ER.

Immunol Res. 2013 Dec;57(1-3):311-25. doi: 10.1007/s12026-013-8468-x. Review.

PMID:
24254084
24.

Humanized mice: novel model for studying mechanisms of human immune-based therapies.

Gonzalez L, Strbo N, Podack ER.

Immunol Res. 2013 Dec;57(1-3):326-34. doi: 10.1007/s12026-013-8471-2. Review.

25.

Immunobiology of TNFSF15 and TNFRSF25.

Schreiber TH, Podack ER.

Immunol Res. 2013 Dec;57(1-3):3-11. doi: 10.1007/s12026-013-8465-0. Review.

PMID:
24242819
26.

Immunology and microbiology in Miami.

Podack ER.

Immunol Res. 2013 Dec;57(1-3):1-2. doi: 10.1007/s12026-013-8470-3. No abstract available.

PMID:
24242762
27.

CD30: from basic research to cancer therapy.

Muta H, Podack ER.

Immunol Res. 2013 Dec;57(1-3):151-8. Review.

28.

CD30 is required for activation of a unique subset of interleukin-17A-producing γδ T cells in innate immunity against Mycobacterium bovis Bacillus Calmette-Guerin infection.

Guo Y, Sun X, Shibata K, Yamada H, Muta H, Podack ER, Yoshikai Y.

Infect Immun. 2013 Oct;81(10):3923-34. doi: 10.1128/IAI.00887-13. Epub 2013 Aug 5.

29.

Perforin-2 restricts growth of Chlamydia trachomatis in macrophages.

Fields KA, McCormack R, de Armas LR, Podack ER.

Infect Immun. 2013 Aug;81(8):3045-54. doi: 10.1128/IAI.00497-13. Epub 2013 Jun 10.

30.

CD30L/CD30 is critical for maintenance of IL-17A-producing γδ T cells bearing Vγ6 in mucosa-associated tissues in mice.

Sun X, Shibata K, Yamada H, Guo Y, Muta H, Podack ER, Yoshikai Y.

Mucosal Immunol. 2013 Nov;6(6):1191-201. doi: 10.1038/mi.2013.18. Epub 2013 Apr 3.

PMID:
23549449
31.

Cutting edge: novel vaccination modality provides significant protection against mucosal infection by highly pathogenic simian immunodeficiency virus.

Strbo N, Vaccari M, Pahwa S, Kolber MA, Doster MN, Fisher E, Gonzalez L, Stablein D, Franchini G, Podack ER.

J Immunol. 2013 Mar 15;190(6):2495-9. doi: 10.4049/jimmunol.1202655. Epub 2013 Feb 11.

32.

Cloning, expression, and functional characterization of TL1A-Ig.

Khan SQ, Tsai MS, Schreiber TH, Wolf D, Deyev VV, Podack ER.

J Immunol. 2013 Feb 15;190(4):1540-50. doi: 10.4049/jimmunol.1201908. Epub 2013 Jan 14.

33.

Inhibition of intracellular bacterial replication in fibroblasts is dependent on the perforin-like protein (perforin-2) encoded by macrophage-expressed gene 1.

McCormack R, de Armas LR, Shiratsuchi M, Ramos JE, Podack ER.

J Innate Immun. 2013;5(2):185-94. doi: 10.1159/000345249. Epub 2012 Dec 15.

34.

T cell costimulation by TNFR superfamily (TNFRSF)4 and TNFRSF25 in the context of vaccination.

Schreiber TH, Wolf D, Bodero M, Gonzalez L, Podack ER.

J Immunol. 2012 Oct 1;189(7):3311-8. Epub 2012 Sep 5.

35.

Tumor antigen specific iTreg accumulate in the tumor microenvironment and suppress therapeutic vaccination.

Schreiber TH, Wolf D, Bodero M, Podack E.

Oncoimmunology. 2012 Aug 1;1(5):642-648.

36.

Tregs expanded in vivo by TNFRSF25 agonists promote cardiac allograft survival.

Wolf D, Schreiber TH, Tryphonopoulos P, Li S, Tzakis AG, Ruiz P, Podack ER.

Transplantation. 2012 Sep 27;94(6):569-74.

PMID:
22902792
37.

TNFRSF25 agonistic antibody and galectin-9 combination therapy controls herpes simplex virus-induced immunoinflammatory lesions.

J Reddy PB, Schreiber TH, Rajasagi NK, Suryawanshi A, Mulik S, Veiga-Parga T, Niki T, Hirashima M, Podack ER, Rouse BT.

J Virol. 2012 Oct;86(19):10606-20. doi: 10.1128/JVI.01391-12. Epub 2012 Jul 18.

38.

IL-2 receptor signaling is essential for the development of Klrg1+ terminally differentiated T regulatory cells.

Cheng G, Yuan X, Tsai MS, Podack ER, Yu A, Malek TR.

J Immunol. 2012 Aug 15;189(4):1780-91. doi: 10.4049/jimmunol.1103768. Epub 2012 Jul 11.

39.

B lymphocyte inhibition of anti-tumor response depends on expansion of Treg but is independent of B-cell IL-10 secretion.

Zhang Y, Eliav Y, Shin SU, Schreiber TH, Podack ER, Tadmor T, Rosenblatt JD.

Cancer Immunol Immunother. 2013 Jan;62(1):87-99. doi: 10.1007/s00262-012-1313-6. Epub 2012 Jul 8.

PMID:
22772949
40.

CD30 ligand/CD30 interaction is involved in pathogenesis of inflammatory bowel disease.

Somada S, Muta H, Nakamura K, Sun X, Honda K, Ihara E, Akiho H, Takayanagi R, Yoshikai Y, Podack ER, Tani K.

Dig Dis Sci. 2012 Aug;57(8):2031-7. doi: 10.1007/s10620-012-2129-0. Epub 2012 Mar 27.

PMID:
22451116
41.

The central role of CD30L/CD30 interactions in allergic rhinitis pathogenesis in mice.

Fuchiwaki T, Sun X, Fujimura K, Yamada H, Shibata K, Muta H, Podack ER, Kawauchi H, Yoshikai Y.

Eur J Immunol. 2011 Oct;41(10):2947-54. doi: 10.1002/eji.201141423. Epub 2011 Aug 30.

42.

CD30: an important new target in hematologic malignancies.

Deutsch YE, Tadmor T, Podack ER, Rosenblatt JD.

Leuk Lymphoma. 2011 Sep;52(9):1641-54. doi: 10.3109/10428194.2011.574761. Epub 2011 May 27. Review.

PMID:
21619423
43.

Immunotherapy as a strategy for the treatment of non-small-cell lung cancer.

Holt GE, Podack ER, Raez LE.

Therapy. 2011 Jan;8(1):43-54.

44.

Gp96 SIV Ig immunization induces potent polyepitope specific, multifunctional memory responses in rectal and vaginal mucosa.

Strbo N, Vaccari M, Pahwa S, Kolber MA, Fisher E, Gonzalez L, Doster MN, Hryniewicz A, Felber BK, Pavlakis GN, Franchini G, Podack ER.

Vaccine. 2011 Mar 21;29(14):2619-25. doi: 10.1016/j.vaccine.2011.01.044. Epub 2011 Jan 28.

45.

The absence of B lymphocytes reduces the number and function of T-regulatory cells and enhances the anti-tumor response in a murine tumor model.

Tadmor T, Zhang Y, Cho HM, Podack ER, Rosenblatt JD.

Cancer Immunol Immunother. 2011 May;60(5):609-19. doi: 10.1007/s00262-011-0972-z. Epub 2011 Jan 21.

PMID:
21253724
46.

TNF superfamily member 13, APRIL, inhibits allergic lung inflammation.

Xiao Y, Motomura S, Deyev V, Podack ER.

Eur J Immunol. 2011 Jan;41(1):164-71. doi: 10.1002/eji.201040436. Epub 2010 Dec 1.

47.

The role of TNFRSF25:TNFSF15 in disease… and health?

Schreiber TH, Wolf D, Podack ER.

Adv Exp Med Biol. 2011;691:289-98. doi: 10.1007/978-1-4419-6612-4_30. Review. No abstract available.

PMID:
21153333
48.

CD30 ligand is a target for a novel biological therapy against colitis associated with Th17 responses.

Sun X, Yamada H, Shibata K, Muta H, Tani K, Podack ER, Iwakura Y, Yoshikai Y.

J Immunol. 2010 Dec 15;185(12):7671-80. doi: 10.4049/jimmunol.1002229. Epub 2010 Nov 10.

49.

Therapeutic Treg expansion in mice by TNFRSF25 prevents allergic lung inflammation.

Schreiber TH, Wolf D, Tsai MS, Chirinos J, Deyev VV, Gonzalez L, Malek TR, Levy RB, Podack ER.

J Clin Invest. 2010 Oct;120(10):3629-40. doi: 10.1172/JCI42933. Epub 2010 Sep 20.

50.

CD30 ligand/CD30 plays a critical role in Th17 differentiation in mice.

Sun X, Yamada H, Shibata K, Muta H, Tani K, Podack ER, Yoshikai Y.

J Immunol. 2010 Aug 15;185(4):2222-30. doi: 10.4049/jimmunol.1000024. Epub 2010 Jul 16.

Supplemental Content

Loading ...
Support Center